Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample

Biological Procedures Online

Volumn 3, Issue 1, 2001, Pages 19-25

  Marone, Maria ^a   Mozzetti, Simona ^a   De Ritis, Daniela ^a   Pierelli, Luca ^a   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

bcl 2; Gene expression; mRNA; RT PCR; Technique

Indexed keywords

EID: 0005261199     PISSN: 14809222     EISSN: None     Source Type: Journal    
DOI: 10.1251/bpo20     Document Type: Article

References (24)

1. PCR technology: principles and applications for DNA amplification. 1989. H.A.Erlich Ed., IRL Press at Oxford Univ. Press, Oxford, UK
2. Carding SR., Lu D, Bottomly KA. 1992. A polymerase chain reaction assay for the detection and quantification of cytokine gene expression in small number of cells. J. Immunol. Methods 151, 277-287.
3. Marone M, Pierelli L, Mozzetti S, Masciullo V, Bonanno G, Morosetti R, Rutella S, Battaglia A, Rumi C, Mancuso S, Leone G, Scambia, G. 2000. High Cyclin-dependent kinase inhibitors and p53 levels in Bcl-2 and Bcl-xL-expressing primitive proliferating hematopoietic progenitors. Br. J. Haematol. 654-662.
4. Pierelli L, Marone M, Bonanno G, Battaglia A, Mozzetti S, Rumi C, Mancuso S, Leone G, Scambia, G. 2000. Modulation of bcl-2 and p27 in primitive, proliferating hematopoietic progenitors by autocrine TGF-beta1 is a cell cycle independent effect and influences their hematopoietic potential. Blood 95, 3001-3010.
5. Marone M, Ferrandina G, Macchia G, Mozzetti S, De Pasqua A, Benedetti-Panici P, Mancuso S, Scambia G. 2001. Bcl-2, bax, bcl-xL and bcl-xS expression in neoplastic and normal endometrium. Oncology 58, 161-168.
6. s expression in normal and neoplastic ovarian tissues. Clinical Cancer Res. 4, 517-524.
7. Marone M, Scambia G, Giannitelli C, Ferrandina G, Masciullo V, Bellacosa A, Benedetti-Panici P, Mancuso S. 1997. Cyclin E and cdk2 alterations in ovarian cancer: amplification and overexpression. Int.J. Cancer 74, 390-395.
8. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F. 1989. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J.Cell.Physiol. 140, 632-634.
9. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY,
10. Wang TTY, Phang JM. 1995. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55, 2487-2489.
11. Chen D, Klebe RJ. 1993. Controls for validation of relative reverse transcription-polymerase chain reaction assays. PCR Methods and Applications 3, 127-129.
12. Freeman WM, Walker SJ, Vrana KE. 1999. Quantitative RT-PCR: pitfalls and potential. BioTechniques 26, 112-125.
13. Ali SA, Sarto I, Steinkasserer A. 1997. Production of PCR mimics for any semiquantitative PCR application. BioTechniques 6, 1060-1062.
14. Corey E, Corey MJ. 1998. Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): technical and clinical aspects. Int J Cancer 77, 655-673.
15. Medhurst AD, Harrison DC, Read SJ, Campbell CA, Robbins MJ, Pangalos MN. 2000. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J.Neurosci.Methods 98, 9-20.
16. Gibson UEM, Heid CA, Williams PM. 1996. A novel method for real time quantitative RT-PCR. Genome Methods 6, 995-1001.
17. Ririe KM, Rasmussen RP, Wittwer CT. 2001. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Analytical Biochem. 245, 154-160.
18. Pfeffer U, Fecarotta E, Vidali G. 1995. Efficient one-tube RT-PCR amplification of rare transcripts using short sequence-specific reverse transcription primers. BioTechniques 18, 204-206.
19. Lion T. 1996. Control genes in reverse transcriptase-polymerase chain reaction assays. Leukemia 10, 1527-1528.
20. Chelly J, Kaplan J-C, Maire P, Gautron S, Kahn A. 1988. Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 858-860.
21. Morosetti R, Park DJ, Chumakov AM, Grillier I, Shiohara M, Gombart AF, Nakamaki T, Wenberg K, Koeffler H. P. 1997. A novel, myeloid transcription factor, C/EBPε, is upregulated during granulocytic, but not monocytic, differentiation. Blood 90, 2591-2600.
22. Foley KP, Leonard MW, Engel JD. 1993. Quantitation of RNA using the polymerase chain reaction. Trends in Genetics 9, 380-385.
23. Souazé F, Ntodou-Thomé A, Tran CY, Rostène W, Forgez P. 1996. Quantitative RT-PCR: limits and accuracy. BioTechniques 21, 280-285.
24. Marone M, Scambia G, Bonanno G, Rutella S, De Ritis D, Guidi F, Mancuso S, Leone G, Pierelli L. 2001. Transforming growth factor-β1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell cycle effects. Leukemia, in press